Document is current
Any future updates will be listed below
-
Authors
Oosterhof, P.
Van Luin, M.
Vanhommerig, J. W.
Brinkman, K.
Burger, D. M.
- License Information
-
More Information
Article History
Received: 3 February 2024
Accepted: 28 April 2025
First Online: 5 May 2025
Declarations
:
: Not applicable. This study utilized an existing database (Foundation for Pharmaceutical Statistics - SFK) in the Netherlands which aggregates anonymized pharmacy data for research purposes. As such, individual patient consent was not required and the study did not involve direct participation. The use of this database for research has been approved by the SFK committee, ensuring compliance with national guidelines for data privacy and ethical research conduct (Foundation for Pharmaceutical Statistics — SFK Website).
: Not applicable.
: PO received personal consulting fees from ViiV healthcare, Gilead, and Merck Sharp & Dohme. KB received personal consultation fees from Merck, Gilead, and ViiV. KB has received a writing honorarium from UpToDate. The remaining authors have no conflicts of interest to declare.
